Delivery Order SPE2DB22D1017-SPE2DB24FF6RK
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $15,275.33, is for the delivery of Biktarvy 50-200-25 MG Tablet, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $54,991.16 for the supply of BIKTARVY 50-200-25 MG TABLET. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 11, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for the provision of Biktarvy 50-200-25 mg tablets valued at $51,091.18. The award was made by the Defense Logistics Agency (DLA), a defense agency, on September 28, 2021, with a completion date of September 29, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order worth $76,466.38 awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has an ultimate completion date of March 1, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,340.78, is a delivery order for Biktarvy 50-200-25 mg tablet with an ultimate completion date of March 1, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
- This federal contract award is a delivery order valued at $3,178.62 issued to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product Biktarvy 50-200-25 mg tablet. The contract has an ultimate completion date of April 17, 2023 and is a firm fixed price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and veterans'...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $144,534.13, is a delivery order for the supply of Biktarvy 50-200-25 mg tablets. It has a completion date of December 12, 2022 and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication, with a ceiling value of $12,630.54 and a completion date of June 12, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order worth $39,342.34 for Biktarvy 50-200-25 mg Tablets, with a completion date of November 2, 2023. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $20,076.27 for the pharmaceutical product Biktarvy 50-200-25 MG Tablet. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), on November 15, 2021 with a completion date of November 16, 2021. The contract is a Firm Fixed Price agreement and was awarded without any set-aside designation, indicating open competition....
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF6RKDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,381.13 for the pharmaceutical product Biktarvy 50-200-25 MG Tablet. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 26, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, as well as a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000. These IDCs enable the efficient procurement of essential pharmaceutical products and medical supplies to support military, veteran, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 4/25/24 |